Reviewing Key Data in Resectable and ROS1+ NSCLC With Drs Florez and Sabari

Narjust Florez, MD, of Dana-Farber Brigham Cancer Center, and Joshua K. Sabari, MD, of NYU Langone Health’s Perlmutter Cancer Center, sit down with Chandler Park, MD, FACP, of Norton Cancer Institute, to discuss the latest abstracts in lung cancer presented during the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer.